National Institute for Health and Care Excellence4d
Efgartigimod with recombinant human hyaluronidase PH20 for treating chronic inflammatory demyelinating polyneuropathy ID6409
Suggested remit: To appraise the clinical and cost effectiveness of efgartigimod with recombinant human hyaluronidase PH20 within its marketing authorisation for treating chronic inflammatory ...
National Institute for Health and Care Excellence5d
Efgartigimod with recombinant human hyaluronidase PH20 for treating chronic inflammatory demyelinating polyneuropathy ID6409
A list of downloadable documents created during development.
National Institute for Health and Care Excellence5d
Introducing CHEERS-AI: improving health economic evaluation reporting for AI technologies
CHEERS-AI builds on existing best practice in health economic evaluation reporting by including the original 28 standards ...
National Institute for Health and Care Excellence5d
More people are benefitting from NICE-recommended statins to reduce heart attacks and strokes
Around 5.3 million people in England were given a NICE-recommended statin or ezetimibe by their GP to help reduce their ...
National Institute for Health and Care Excellence6d
Atezolizumab for adjuvant treatment of renal cell carcinoma with a high risk of metastasis [ID5101]
A list of downloadable documents created during development.